Abstract
Adenosine, a modulator of pain processing in the spinal cord, is metabolized by adenosine kinase and adenosine deaminase. In this study we determined which of these mechanisms is more important for the regulation of endogenous adenosine levels in the rat spinal cord. The effects of the adenosine kinase inhibitors, 5′-deoxyadenosine (NH2dAD) and iodotubercidin (IOT), and the adenosine deaminase inhibitor, 2′-deoxycoformycin (DCF), on adenosine release in a spinal cord superfusion model were studied. DCF markedly increased basal adenosine levels detected in perfusates and was more potent than NH2dAD and IOT in this regard. Coadministration of DCF with NH2dAD produced an enhanced effect compared to the inhibitors alone. NH2dAD, but not DCF, potentiated morphine-evoked adenosine release. These results suggest that adenosine deaminase may be the predominant pathway for adenosine metabolism in this experimental model.
Original language | English |
---|---|
Pages (from-to) | 315-320 |
Number of pages | 6 |
Journal | Brain Research |
Volume | 699 |
Issue number | 2 |
DOIs | |
Publication status | Published - Nov 20 1995 |
Bibliographical note
Funding Information:This work was supported by the Medical Research Council of Canada. We thank Parke Davies Pharmaceuticals for the provision of 2'-deoxycoformycin.
ASJC Scopus Subject Areas
- General Neuroscience
- Molecular Biology
- Clinical Neurology
- Developmental Biology
PubMed: MeSH publication types
- Journal Article
- Research Support, Non-U.S. Gov't